Literature DB >> 22264217

The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.

Gary S Wand1, Elise M Weerts, Hiroto Kuwabara, Dean F Wong, Xiaoqiang Xu, Mary E McCaul.   

Abstract

Hypothalamic-pituitary-adrenal (HPA) axis responses following naloxone administration have been assumed to provide a measure of opioid receptor activity. Employing positron emission tomography (PET) using the mu opioid receptor (MOR) selective ligand [(11)C] carfentanil (CFN), we demonstrated that cortisol responses to naloxone administration were negatively correlated with MOR availability. In this study, we examined whether naloxone-induced cortisol and adrenocorticotropin (ACTH) responses in 15 healthy control and 20 recently detoxified alcohol-dependent subjects correlated with delta opioid receptor (DOR) availability in 15 brain regions using the DOR-selective ligand [(11)C] methyl-naltrindole (MeNTL) and PET imaging. The day after the scan, cortisol responses to cumulative doses of naloxone were determined. Peak cortisol and ACTH levels and area under the cortisol and ACTH curve did not differ by group. There were negative relationships between cortisol area under curve to naloxone and [(11)C] MeNTL-binding potential (BP(ND)) in the ventral striatum, anterior cingulate, fusiform cortices, temporal cortex, putamen and a trend in the hypothalamus of healthy control subjects. However, in alcohol-dependent subjects, cortisol responses did not correlate with [(11)C]MeNTL BP(ND) in any brain region. Plasma ACTH levels did not correlate with [(11)C]MeNTL BP(ND) in either group. The study demonstrates that naloxone provides information about individual differences in DOR availability in several mesolimbic structures. The data also show that the HPA axis is intimately connected with mesolimbic stress pathways through opioidergic neurotransmission in healthy subjects but this relationship is disrupted during early abstinence in alcohol-dependent subjects.
© 2012 The Authors, Addiction Biology © 2012 Society for the Study of Addiction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22264217      PMCID: PMC3337889          DOI: 10.1111/j.1369-1600.2011.00430.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  63 in total

1.  Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

Authors:  J T Sullivan; K Sykora; J Schneiderman; C A Naranjo; E M Sellers
Journal:  Br J Addict       Date:  1989-11

2.  Mu opiate receptors are selectively labelled by [3H]carfentanil in human and rat brain.

Authors:  M Titeler; R A Lyon; M J Kuhar; J F Frost; R F Dannals; S Leonhardt; A Bullock; L T Rydelek; D L Price; R G Struble
Journal:  Eur J Pharmacol       Date:  1989-08-22       Impact factor: 4.432

3.  Localization of preproenkephalin mRNA in the rat brain and spinal cord by in situ hybridization.

Authors:  R E Harlan; B D Shivers; G J Romano; R D Howells; D W Pfaff
Journal:  J Comp Neurol       Date:  1987-04-08       Impact factor: 3.215

4.  Alcohol dependence syndrome: measurement and validation.

Authors:  H A Skinner; B A Allen
Journal:  J Abnorm Psychol       Date:  1982-06

5.  Confirmation that offspring from families with alcohol-dependent individuals have greater hypothalamic-pituitary-adrenal axis activation induced by naloxone compared with offspring without a family history of alcohol dependence.

Authors:  G Wand; M E McCaul; D Gotjen; J Reynolds; S Lee
Journal:  Alcohol Clin Exp Res       Date:  2001-08       Impact factor: 3.455

6.  Design of peptidomimetic delta opioid receptor antagonists using the message-address concept.

Authors:  P S Portoghese; M Sultana; A E Takemori
Journal:  J Med Chem       Date:  1990-06       Impact factor: 7.446

7.  Comparison of [11C]diprenorphine and [11C]carfentanil binding to opiate receptors in humans by positron emission tomography.

Authors:  J J Frost; H S Mayberg; B Sadzot; R F Dannals; J R Lever; H T Ravert; A A Wilson; H N Wagner; J M Links
Journal:  J Cereb Blood Flow Metab       Date:  1990-07       Impact factor: 6.200

8.  Naloxone and its quaternary derivative, naloxone methiodide, have differing affinities for mu, delta, and kappa opioid receptors in mouse brain homogenates.

Authors:  Tanya Lewanowitsch; Rodney James Irvine
Journal:  Brain Res       Date:  2003-02-28       Impact factor: 3.252

9.  Anatomical localization for PET using MR imaging.

Authors:  C C Meltzer; R N Bryan; H H Holcomb; A W Kimball; H S Mayberg; B Sadzot; J P Leal; H N Wagner; J J Frost
Journal:  J Comput Assist Tomogr       Date:  1990 May-Jun       Impact factor: 1.826

Review 10.  Opioids and alcoholism.

Authors:  L M Oswald; G S Wand
Journal:  Physiol Behav       Date:  2004-04
View more
  8 in total

1.  The relationship between naloxone-induced cortisol and mu opioid receptor availability in mesolimbic structures is disrupted in alcohol dependent subjects.

Authors:  Gary S Wand; Elise M Weerts; Hiroto Kuwabara; Dean F Wong; Xiaoqiang Xu; Mary E McCaul
Journal:  Alcohol       Date:  2012-06-18       Impact factor: 2.405

2.  A new biomarker of hedonic eating? A preliminary investigation of cortisol and nausea responses to acute opioid blockade.

Authors:  Jennifer Daubenmier; Robert H Lustig; Frederick M Hecht; Jean Kristeller; Josh Woolley; Tanja Adam; Mary Dallman; Elissa Epel
Journal:  Appetite       Date:  2013-11-27       Impact factor: 3.868

Review 3.  The delta opioid receptor tool box.

Authors:  Ana Vicente-Sanchez; Laura Segura; Amynah A Pradhan
Journal:  Neuroscience       Date:  2016-06-24       Impact factor: 3.590

Review 4.  Delta Opioid Pharmacology in Relation to Alcohol Behaviors.

Authors:  Doungkamol Alongkronrusmee; Terrance Chiang; Richard M van Rijn
Journal:  Handb Exp Pharmacol       Date:  2018

5.  Attenuation of morphine withdrawal signs, blood cortisol and glucose level with forced exercise in comparison with clonidine.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Majid Asadi-Ghalehni; Ozra Motaghinejad
Journal:  Adv Biomed Res       Date:  2014-08-19

Review 6.  Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework.

Authors:  Mark K Greenwald
Journal:  Neurobiol Stress       Date:  2018-08-11

Review 7.  Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.

Authors:  Jamie A Burns; Danielle S Kroll; Dana E Feldman; Christopher Kure Liu; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang
Journal:  Front Psychiatry       Date:  2019-09-18       Impact factor: 4.157

8.  Naloxone precipitated withdrawal increases dopamine release in the dorsal striatum of opioid dependent men.

Authors:  Ehsan Shokri-Kojori; Gene-Jack Wang; Nora D Volkow
Journal:  Transl Psychiatry       Date:  2021-09-01       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.